ETF · holdings as filed 2026-04-30
What's inside PBE?
Invesco Biotechnology & Genome ETF
- Holdings
- 33
- positions in the fund
- Top 10
- 48%
- of fund assets
- Expense ratio
- 0.58%
- net, per year
- Fund size
- $247M
- total net assets
Top 20 holdings
| Rank | Logo | Ticker / Name | Weight | |
|---|---|---|---|---|
| 1 | ? | —Invesco Private Prime Fund | 9.47% | |
| 2 | U  | UTHRUNITED THERAPEUTICS CORP | 5.45% | |
| 3 | I  | ILMNILLUMINA INC | 4.66% | |
| 4 | B  | BIIBBIOGEN INC | 4.38% | |
| 5 | I  | INCYINCYTE CORP | 4.26% | |
| 6 | A  | ALNYALNYLAM PHARMACEUTICALS INC | 4.20% | |
| 7 | R  | REGNREGENERON PHARMACEUTICALS | 4.14% | |
| 8 | A  | AMGNAMGEN INC | 4.09% | |
| 9 | G  | GILDGILEAD SCIENCES INC | 4.00% | |
| 10 | ? | —Invesco Private Government Fund | 3.65% | |
| 11 | B  | BCRXBIOCRYST PHARMACEUTICALS INC | 2.97% | |
| 12 | ? | —CATALYST PHARMACEUTICALS, INC. | 2.87% | |
| 13 | A  | ARWRARROWHEAD PHARMACEUTICALS IN | 2.84% | |
| 14 | P  | PTGXPROTAGONIST THERAPEUTICS INC | 2.79% | |
| 15 | T  | TGTXTG THERAPEUTICS INC | 2.73% | |
| 16 | R  | RPRXROYALTY PHARMA PLC- CL A | 2.72% | |
| 17 | C  | CDNACAREDX INC | 2.66% | |
| 18 | N  | NBIXNEUROCRINE BIOSCIENCES INC | 2.48% | |
| 19 | E  | EXELEXELIXIS INC | 2.43% | |
| 20 | T  | TECHBIO-TECHNE CORP | 2.37% |
Top holdings — Health Care
Your 10 largest positions in this sector
1
U
UTHRUNITED THERAPEUTICS CORP
5.45%2
I
ILMNILLUMINA INC
4.66%3
B
BIIBBIOGEN INC
4.38%4
A
ALNYALNYLAM PHARMACEUTICALS INC
4.20%5
R
REGNREGENERON PHARMACEUTICALS
4.14%6
A
AMGNAMGEN INC
4.09%7
G
GILDGILEAD SCIENCES INC
4.00%8
B
BCRXBIOCRYST PHARMACEUTICALS INC
2.97%9
A
ARWRARROWHEAD PHARMACEUTICALS IN
2.84%10
P
PTGXPROTAGONIST THERAPEUTICS INC
2.79%Top holdings — United States
Your 10 largest positions in this country
1
U
UTHRUNITED THERAPEUTICS CORP
5.45%2
I
ILMNILLUMINA INC
4.66%3
B
BIIBBIOGEN INC
4.38%4
I
INCYINCYTE CORP
4.26%5
A
ALNYALNYLAM PHARMACEUTICALS INC
4.20%6
R
REGNREGENERON PHARMACEUTICALS
4.14%7
A
AMGNAMGEN INC
4.09%8
G
GILDGILEAD SCIENCES INC
4.00%9
B
BCRXBIOCRYST PHARMACEUTICALS INC
2.97%10
A
ARWRARROWHEAD PHARMACEUTICALS IN
2.84%Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold PBE alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Funds similar to PBE
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
Informational and educational only — not investment advice.